Govt. and Industry News
September 2017 | News: Dr. Vijay Soni NASI-Young Scientist Platinum Jubilee Award for the year 2017, in the field of Biology
Dr. Soni’s research has been published in two prestigious international science journals- PLOS Pathogen (in 2015)
and Journal of Biological Chemistry (in 2012). Dr. Vijay has 12 international publications to his credit as well one patent on the new antituberculosis molecule Oxa33. He was also honored by Inspiring Science Award 2017 by TNQ-Cell Press, BioAsia Innovation award 2016 from Global BioBusiness Forum, and Global Health Award from Bill and Melinda Gates Foundation for his discovery on GlmU and Oxa33.
May 2017 | News: Prof Ashok Pandey appears in the list of Most Cited Author released by Shanghai Ranking’s Global Ranking of Academic Subjects 2016 by Elsevier.
His major research interests are in the areas of microbial, enzyme and bioprocess technology, which spans over various programs, including probiotics and nutraceuticals and microbial bioactives for drug development and health benefits. He has >1100publications/ communications, which include 16 patents, 50 books, 125 book chapters, 425 original and review papers, etc with h index of 74 and >23,500 citation (Goggle scholar).
May 2017 | DBT Strategy meet discusses roadmap for societal impact & $100 bn Biotech industry
The strategy meet of the Department of Biotechnology (DBT) brought together experts from Biotechnology Sector to suggest a roadmap to strengthen the Department’s current programs further with an aim to achieve major social impact by 2022, the 75th anniversary of India’s independence and a $100 billion Indian biotechnology sector by 2025.
April 2017 | News: Government aims to make India a global Biotech Hub by 2020
Globally, BIRAC has been hailed as one of the most effective government measures to create an enabling environment for research and development to flourish in a country, “said Mr. Y. S. Chowdary, Minister of State for Science and Technology and Earth Sciences while inaugurating the 5th Foundation day celebrations.
March 2017 | Prof. Kambadur Muralidhar Joined Jawaharlal Nehru Chair Professor in School of Life Sciences, University of Hyderabad recently
Kambadur Muralidhar initiated and nurtured a long range research programme on the Biochemical Endocrinology of the Indian water buffalo at the Universities of Hyderabad and Delhi resulting in the completion of 26 PhDs and 26 M Phil theses and more than 135 publications in peer reviewed journals and book chapters.
News: Professor Ashok Pandey joined DBT- CIAB as Eminent Scientist.
Prof Ashok Pandey has been appointed as Eminent Scientist at the Centre for Innovative and Applied Bioprocessing (CIAB), Mohali, Punjab, India, which is a Govt of India institute under the Department of Biotechnology, Ministry of Science and Technology.
News: National Biotechnology Development Strategy, DBT VISION 2015-2020 & Highlights of Global Biotechnology Summit 2016, India
The National Biotechnology Development Strategy of the Department of Biotechnology was unveiled by Hon’ble Minister for Science and Technology and Earth Sciences Dr Harsh Vardhan and Hon’ble Minister of State for Science and Technology and Earth Sciences in the presence of Secretary, DBT, Dr. VijayRaghavan and other Key Stakeholders in New Delhi on 30th December 2015.
News: Frogman of India
Yes, I am talking about Frogs. But whether this creature can be a study of interest to someone? Or one person can
be named on that? Yes, it happened for University of Delhi biologist Dr. Sathyabhama Das Biju, who is called the
frog man of India and the frog fanatic. In the last 15 years, Dr Biju and his team of scientists have discovered 89 of India’s 388 frog species. He says more than 100 species have to be discovered.
News: CSIR Launched Ayurvedic, safe Antidiabetic Drug – BGR- 34
A scientifically confirmed anti-diabetes herbal drug, known as ‘BGR-34, was released by a Council of Scientific and Industrial Research (CSIR) lab in Lucknow, India on 25th of October 2015. A combo of natural ingredients from plants, the drug is based on Ayurveda and has no side effects. The drug is for control of type-II diabetes mellitus.